Profile
Ann Neale currently works at BioAge Labs, Inc., as Chief Development Officer from 2021, Principia Biopharma, Inc., as Senior Vice President-Development Operations, and Science 37, Inc., as SVP Clinical Operations & Patient Affairs from 2017.
Ms. Neale also formerly worked at Saegis Pharmaceuticals, Inc., as Vice President-Clinical Operations from 2004 to 2006.
Ms. Neale received her undergraduate degree from the University of Minnesota.
Ann Neale active positions
| Companies | Position | Start |
|---|---|---|
| BIOAGE LABS, INC. | Corporate Officer/Principal | 01/11/2021 |
| PRINCIPIA BIOPHARMA INC. | Corporate Officer/Principal | - |
Science 37, Inc.
Science 37, Inc. BiotechnologyHealth Technology Develops mobile technology, clinical trials and patient-centric models for clinical research | Corporate Officer/Principal | 01/01/2017 |
Former positions of Ann Neale
| Companies | Position | End |
|---|---|---|
Saegis Pharmaceuticals, Inc.
Saegis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapeutics | Corporate Officer/Principal | 01/01/2006 |
Training of Ann Neale
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Principia Biopharma, Inc.
Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saegis Pharmaceuticals, Inc.
Saegis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapeutics | Health Technology |
Science 37, Inc.
Science 37, Inc. BiotechnologyHealth Technology Develops mobile technology, clinical trials and patient-centric models for clinical research | Health Technology |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology Develops therapies obesity for metabolic diseases | Health Technology |
- Stock Market
- Insiders
- Ann Neale
















